Advertisement
News
Subscribe to MDT Magazine News

New Biosensing Technology Could Facilitate Personalized Medicine

September 20, 2010 9:33 am | by Georgia Tech Institute of Technology | Comments

The microplate, a standard tool in biomedical research and diagnostic laboratories, could become a thing of the past thanks to new electronic biosensing technology developed by a team of microelectronics engineers and biomedical scientists.

TOPICS:

CSA Medical, Inc. Announces 75th Customer

September 20, 2010 7:32 am | by Bio-Medicine.Org | Comments

BALTIMORE, Sept. 20 /- CSA Medical, Inc. announced today that New York University Langone Medical Center (NYU) has begun providing Spray Cryotherapy treatment for patients. Dr. Costas (Gus) Bizekis, Assistant Professor of Medicine, in the department of Cardiothoracic Surgery is performing...

TOPICS:

Abaxis, Inc. to Present at Sidoti & Company's Ninth Annual West Coast Institutional Investor Forum

September 20, 2010 7:32 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., Sept. 20 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the Sidoti & Company's Ninth Annual West Coast...

TOPICS:
Advertisement

Accuray Incorporated to Speak at JMP Securities Healthcare Conference

September 20, 2010 7:32 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Sept. 20 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the JMP Securities Healthcare Conference in New York City on Tuesday, September 28, 2010 at 11:30 a.m. ET/8:30...

TOPICS:

Boston Scientific to buy privately held Asthmatx

September 20, 2010 6:45 am | by The Associated Press | Comments

Boston Scientific will buy privately held Asthmatx Inc. in a deal that could be worth more than $440 million, the medical device maker said Monday. Boston Scientific, which is based in Natick, Mass., said it will pay $193.5 million upfront in cash. It will then make additional payments of up to...

TOPICS:

Aromatase Inhibitors in Products Marketed as Dietary Supplements: Recall

September 20, 2010 6:32 am | by U.S. Food & Drug Administration | Comments

Serious adverse events, especially for consumers with liver, kidney, adrenal, or prostate abnormalities, associated with the use of aromatase inhibitors.

Federal Register: Risk Communication Advisory Committee; Notice of Meeting

September 20, 2010 6:32 am | by U.S. Food & Drug Administration | Comments

On November 8 and 9, 2010, the Committee will hear and discuss developments in FDA's ongoing communications programs, such as FDA's Strategic Plan for Risk Communication, FDA's Transparency Initiative, and the challenges of effectively communicating...

South Carolina Optometrists Partner with State Legislators and Local Mayors in Improving Infant Eye and Vision Care

September 20, 2010 6:31 am | by Bio-Medicine.Org | Comments

CHARLESTON, S.C., Sept. 20 /- Due to the overwhelming number of children with eye and vision problems across the United States, South Carolina optometrists are devoting appointments to no-cost, comprehensive eye and vision assessments for infants between six to 12 months of age through...

TOPICS:
Advertisement

LifePoint Hospitals to offer $400M in senior notes

September 20, 2010 5:45 am | by The Associated Press | Comments

LifePoint Hospitals Inc. said Monday it will sell through a private offering $400 million in senior notes due in 2020.The company will use proceeds to repay $249.2 million in outstanding loans under its senior secured credit facilities. It also may use some proceeds to buy back stock pursuant...

Boston Scientific buys asthma treatment firm

September 20, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Natick medical device maker Boston Scientific Corp. has signed a deal, potentially worth up to $443.5 million, to acquire Asthmatx Inc., a Calif. company that manufactures a catheter-based bronchial thermoplasty procedure for treatment of asthma.

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin T at the Point of Care

September 20, 2010 4:34 am | by Bio-Medicine.Org | Comments

AQT90 FLEX Opens Up for a New and Better Way of Measuring Troponin... -- COPENHAGEN, September 20, 2010 /-

TOPICS:

Boston Scientific to Acquire Asthmatx

September 20, 2010 4:33 am | by Boston Scientific | Comments

Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma

TOPICS:

Questcor to Present at UBS Global Life Sciences Conference

September 20, 2010 4:33 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., Sept. 20 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced today that it will present at the UBS Global Life Sciences Conference on Wednesday, September 22, 2010 at The Grand Hyatt Hotel in New York. Don M. Bailey, President and Chief Executive Officer, will...

TOPICS:

Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent

September 20, 2010 4:32 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Sept. 20 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that the U.S. Patent and Trademark Office granted the Company its 100th patent, a major intellectual property milestone. The 100th patent, U.S. patent No. 7,772,950, covers the "Method and Apparatus for Dynamic...

TOPICS:

Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India

September 20, 2010 1:35 am | by Bio-Medicine.Org | Comments

PARIS and NEW DELHI, India, Sept. 20 /- Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), and Helix BioService & Consultants Pvt Ltd (Helix Biocon), today announced that they will join forces for the promotion of Cellectis...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading